Mereo BioPharma Group PLC ADR (MREO) financials · $48.7M cap
Mereo BioPharma Group PLC ADR (MREO) $48.7M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $500.0K | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$40.1M | -$47.4M |
| Net Income | -$41.9M | -$43.3M |
| EPS (Diluted) | $-0.05 | $-0.06 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $45.9M | $76.4M |
| Current Assets | $45.0M | $74.8M |
| Cash & Equivalents | $41.0M | $69.8M |
| Inventory | $0 | $0 |
| PP&E | $137.0K | $257.0K |
| Total Liabilities | $5.0M | $15.4M |
| Current Liabilities | $4.3M | $13.8M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $40.9M | $61.0M |
| Retained Earnings | -$501.0M | -$462.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$31.0M | -$32.8M |
| CapEx | $20.0K | $0 |
| Investing Cash Flow | -$20.0K | -$699.0K |
| Financing Cash Flow | $327.0K | $46.1M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $12.4M |
| Free Cash Flow | -$31.0M | -$32.8M |
FAQ
What is MREO P/E and revenue?
Mereo BioPharma Group PLC ADR (MREO) $48.7M cap.
What is MREO revenue?
Mereo BioPharma Group PLC ADR last cached revenue is $500.0K (FY2025).
Is MREO profitable?
Mereo BioPharma Group PLC ADR last cached net income is -$41.9M.
What are MREO total assets?
Mereo BioPharma Group PLC ADR last cached total assets are $45.9M.
What is MREO free cash flow?
Mereo BioPharma Group PLC ADR last cached free cash flow is -$31.0M.
Not investment advice. Cached statements, not a live tape.